Question Bank › Disproportional response

Disproportional response

Disproportional response: a small company's current business is visibly outgrowing its own size

Calls Tested
491
Answered YES
4
Hit Rate
0.8%
rare by design

GoodRx Holdings, Inc. (GDRX) — this company's answers

NO on the Q2 2022 call 2022-08-08 F
The model's full reasoning — Q2 2022 call → NOWe need to determine if management conveys that the business is currently outgrowing the company's size, i.e., that what is happening now is disproportionately large relative to the company's smallness. Look for statements about current activity, demand, commitments, volumes, etc., that are large relative to the company's current scale. In the transcript, management discusses the grocer issue, revenue impacts, and growth in other areas. They mention that pharma manufacturer solutions revenue grew 102% year-over-year, but that's growth, not necessarily disproportion. They also mention that they have penetrated less than 1% of a $30 billion TAM, but that's a market size statistic, not current activity. They talk about new user counts being close to prior levels, but that's not a disproportion. They mention that the grocer issue caused a $30 million revenue hit, which is significant relative to their revenue, but that's a loss, not growth. They also mention that they are taking actions to improve cost structure, but that's not about scale. The key question: does management convey that the company is small and that what is happening now is disproportionately large? For example, they might say that a single contract or partnership could rival the company's size, or that they are handling volumes that would have been out of reach until now. I don't see such statements. They talk about growth in pharma manufacturer solutions, but they don't say it's large relative to the company's size. They mention that they have a large TAM, but that's generic. They also mention that they are expanding into new areas like vitaCare, but that's an acquisition, not necessarily a disproportion. The transcript is mostly about the grocer issue and its impact, and about guidance. There is no explicit statement that the company is small and that current business is disproportionately large. They do say that they are a leading brand, but that doesn't imply disproportion. Thus, the answer is NO.

← Back to the full GDRX analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup — that is, does management describe current activity, demand, or commitments arriving at a scale that is large relative to how small the company still is, so that the reported results look like the early portion of something meaningfully bigger rather than a full picture of the business? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent situation: the company is small, and what is happening to it now is disproportionately large compared with that smallness. Any genuine expression of this counts, and the form varies widely across industries. For example — management noting that the business it is winning, booking, or being asked to do is large next to the company's current revenue, footprint, or headcount; that a single customer, contract, program, product, or market now in motion could by itself rival or exceed a meaningful share of today's company; that the company is handling, preparing for, or committing to volumes, projects, or relationships that would have been out of reach for a company of its size until now; that the same absolute wins keep translating into outsized percentage change because the base is still small; or management explicitly contrasting how little the company has captured so far with the scale of what is already reaching it. What matters is the DISPROPORTION, stated or plainly implied by management itself, between the size of the company and the size of what is currently arriving or being committed to it — grounded in real, present-tense business (orders, customers, work, volumes, commitments, or activity happening now), not in market-size statistics, pipelines, or hopes. Answer NO if the company is large relative to what it describes, or already a leading participant with no meaningful disproportion ahead of it. NO if management simply reports strong demand, a good quarter, or healthy growth in the ordinary way without conveying that what is arriving is large relative to the company's own small size. NO if the 'big opportunity' language is a generic total-addressable-market figure, an industry forecast, or promotional talk about a huge market with no reference to how little of it this company has taken or how small the company is against what is already reaching it. NO if the large-scale business described is only prospective — a market not yet entered, an approval or decision still pending, a customer still being pursued, a product still being developed — rather than something already arriving or already committed. NO if the disproportion is described only as a dependency risk or concentration concern management is trying to reduce. NO if the idea appears only in an analyst's question or characterization that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
KOPN Kopin Corporation Q4 2023 2024-03-14 C+
TMCI Treace Medical Concepts, Inc. Q2 2022 2022-08-13 B+
VNRX VolitionRx Limited Q1 2022 2022-05-12 F
FLUX Flux Power Holdings, Inc. Q2 2022 2022-02-10 D

How the model reasoned

VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.

More from the question bank

Operating in the future tenseBreak from their own historyThe open question just closedQ&A has flipped from problems to possibilitiSold before it existsCheap-to-serve incremental businessAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.